Global Artificial Heart Lung Machines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Artificial Heart Lung Machines market size was valued at US$ 327 million in 2025 and is forecast to a readjusted size of US$ 408 million by 2032 with a CAGR of 3.2% during review period.
Artificial Heart Lung Machines are critical medical devices used in extracorporeal circulation during surgery, temporarily replacing the functions of the heart and lungs to maintain continuous blood circulation and oxygenation. The system mainly consists of a blood pump, oxygenator, heat exchanger, tubing system, and monitoring modules, which withdraw blood from the body, oxygenate and regulate its temperature, and return it to the patient, providing safe and stable extracorporeal support for cardiac surgeries, complex major vascular procedures, and heart transplants. The core function of artificial heart lung machines is to ensure adequate tissue oxygenation and hemodynamic stability during surgery, minimizing the risks associated with cardiac arrest and hypoperfusion, thereby enhancing surgical safety and postoperative recovery. With the advancement of cardiac surgery, the adoption of minimally invasive techniques, and the promotion of precision perioperative management, artificial heart lung machines have become indispensable auxiliary devices in modern cardiac operations, also playing crucial roles in clinical research, intensive care, and heart transplantation.In 2025, global Artificial Heart Lung Machines production reached approximately 1224 Units and price is about 260 K USD/Unit.The average gross profit margin of this product is 45%.
The artificial heart lung machine market is driven by multiple factors, with the increasing global burden of cardiovascular diseases and the rising number of high-risk surgeries being primary drivers. Population aging and the rising prevalence of chronic heart conditions have increased the demand for cardiac and complex vascular surgeries, providing a stable market foundation for high-performance extracorporeal circulation devices. Meanwhile, the rapid development of minimally invasive cardiac procedures, heart transplantation, and complex major vascular surgeries has elevated requirements for device performance and reliability, driving manufacturers to continuously innovate and upgrade products. Clinical studies demonstrate that high-precision artificial heart lung machines significantly improve intraoperative hemodynamic stability, reduce organ ischemia risk, and enhance postoperative recovery, further encouraging hospitals to adopt advanced equipment. Advances in intelligent control, integrated modules, and remote monitoring technologies also create new growth opportunities in the market.
Despite technological maturity, the market faces multiple challenges. Some healthcare institutions lack awareness of the devices’ value, resulting in regional disparities in deployment. High equipment costs and disposable consumables, combined with limited hospital budgets, constrain market penetration. Device operation is complex, requiring extensive training and clinical experience, which raises the adoption barrier. Additionally, factors such as blood compatibility, air embolism risk, and potential equipment malfunctions may affect surgical safety, representing inherent risks. Differences in brand performance, modularity, and maintenance convenience may also influence hospital purchasing decisions and market competition.
With the expansion and advancement of cardiac surgery, demand for artificial heart lung machines is trending toward greater intelligence, precision, and safety. Utilization is particularly pronounced in high-risk surgeries, heart transplants, and procedures for elderly patients. The growth of minimally invasive and enhanced recovery surgeries also places higher demands on device performance, controllability, and modular design. In the future, as digital operating rooms and intelligent monitoring systems become more widespread, artificial heart lung machines are expected to achieve deeper integration with surgical workstations, patient monitoring systems, and clinical information platforms, providing real-time support for intraoperative decision-making and enabling more refined perioperative management.
The upstream industry for artificial heart lung machines primarily includes high-precision blood pumps, motor and drive modules, oxygenator materials, heat exchangers, and medical tubing systems. Blood pumps and motor modules are core hardware, directly affecting circulation stability and accuracy. Oxygenator and heat exchanger materials require high standards in blood compatibility, oxygenation efficiency, and temperature regulation, while medical tubing and disposable consumables are critical for safety and biocompatibility. With advancements in medical materials science and microelectronic control technologies, upstream innovation will continue to enhance performance, safety, and intelligence, supporting product differentiation and market expansion.
This report is a detailed and comprehensive analysis for global Artificial Heart Lung Machines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Artificial Heart Lung Machines market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Artificial Heart Lung Machines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Artificial Heart Lung Machines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Artificial Heart Lung Machines market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Heart Lung Machines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Heart Lung Machines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Shenzhen Hannuo, Fresenius, Changzheng Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Artificial Heart Lung Machines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Heart Lung Machines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Artificial Heart Lung Machines, with price, sales quantity, revenue, and global market share of Artificial Heart Lung Machines from 2021 to 2026.
Chapter 3, the Artificial Heart Lung Machines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Heart Lung Machines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Artificial Heart Lung Machines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Artificial Heart Lung Machines.
Chapter 14 and 15, to describe Artificial Heart Lung Machines sales channel, distributors, customers, research findings and conclusion.
Artificial Heart Lung Machines are critical medical devices used in extracorporeal circulation during surgery, temporarily replacing the functions of the heart and lungs to maintain continuous blood circulation and oxygenation. The system mainly consists of a blood pump, oxygenator, heat exchanger, tubing system, and monitoring modules, which withdraw blood from the body, oxygenate and regulate its temperature, and return it to the patient, providing safe and stable extracorporeal support for cardiac surgeries, complex major vascular procedures, and heart transplants. The core function of artificial heart lung machines is to ensure adequate tissue oxygenation and hemodynamic stability during surgery, minimizing the risks associated with cardiac arrest and hypoperfusion, thereby enhancing surgical safety and postoperative recovery. With the advancement of cardiac surgery, the adoption of minimally invasive techniques, and the promotion of precision perioperative management, artificial heart lung machines have become indispensable auxiliary devices in modern cardiac operations, also playing crucial roles in clinical research, intensive care, and heart transplantation.In 2025, global Artificial Heart Lung Machines production reached approximately 1224 Units and price is about 260 K USD/Unit.The average gross profit margin of this product is 45%.
The artificial heart lung machine market is driven by multiple factors, with the increasing global burden of cardiovascular diseases and the rising number of high-risk surgeries being primary drivers. Population aging and the rising prevalence of chronic heart conditions have increased the demand for cardiac and complex vascular surgeries, providing a stable market foundation for high-performance extracorporeal circulation devices. Meanwhile, the rapid development of minimally invasive cardiac procedures, heart transplantation, and complex major vascular surgeries has elevated requirements for device performance and reliability, driving manufacturers to continuously innovate and upgrade products. Clinical studies demonstrate that high-precision artificial heart lung machines significantly improve intraoperative hemodynamic stability, reduce organ ischemia risk, and enhance postoperative recovery, further encouraging hospitals to adopt advanced equipment. Advances in intelligent control, integrated modules, and remote monitoring technologies also create new growth opportunities in the market.
Despite technological maturity, the market faces multiple challenges. Some healthcare institutions lack awareness of the devices’ value, resulting in regional disparities in deployment. High equipment costs and disposable consumables, combined with limited hospital budgets, constrain market penetration. Device operation is complex, requiring extensive training and clinical experience, which raises the adoption barrier. Additionally, factors such as blood compatibility, air embolism risk, and potential equipment malfunctions may affect surgical safety, representing inherent risks. Differences in brand performance, modularity, and maintenance convenience may also influence hospital purchasing decisions and market competition.
With the expansion and advancement of cardiac surgery, demand for artificial heart lung machines is trending toward greater intelligence, precision, and safety. Utilization is particularly pronounced in high-risk surgeries, heart transplants, and procedures for elderly patients. The growth of minimally invasive and enhanced recovery surgeries also places higher demands on device performance, controllability, and modular design. In the future, as digital operating rooms and intelligent monitoring systems become more widespread, artificial heart lung machines are expected to achieve deeper integration with surgical workstations, patient monitoring systems, and clinical information platforms, providing real-time support for intraoperative decision-making and enabling more refined perioperative management.
The upstream industry for artificial heart lung machines primarily includes high-precision blood pumps, motor and drive modules, oxygenator materials, heat exchangers, and medical tubing systems. Blood pumps and motor modules are core hardware, directly affecting circulation stability and accuracy. Oxygenator and heat exchanger materials require high standards in blood compatibility, oxygenation efficiency, and temperature regulation, while medical tubing and disposable consumables are critical for safety and biocompatibility. With advancements in medical materials science and microelectronic control technologies, upstream innovation will continue to enhance performance, safety, and intelligence, supporting product differentiation and market expansion.
This report is a detailed and comprehensive analysis for global Artificial Heart Lung Machines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Artificial Heart Lung Machines market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Artificial Heart Lung Machines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Artificial Heart Lung Machines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Artificial Heart Lung Machines market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Heart Lung Machines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Heart Lung Machines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Shenzhen Hannuo, Fresenius, Changzheng Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Artificial Heart Lung Machines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Single Roller Pump HLM
- Double Roller Pump HLM
- Open Surgery
- Minimally Invasive
- Emergency Surgery
- General Hospitals
- Surgical Centers
- Other
- Cardiac Surgery
- Lung Transplant Operation
- Acute Respiratory Failure Treatment
- Others
- LivaNova (Sorin)
- Getinge (Maquet)
- Medtronic
- Terumo CV Group
- Braile Biomedica
- Shenzhen Hannuo
- Fresenius
- Changzheng Medical
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Heart Lung Machines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Artificial Heart Lung Machines, with price, sales quantity, revenue, and global market share of Artificial Heart Lung Machines from 2021 to 2026.
Chapter 3, the Artificial Heart Lung Machines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Heart Lung Machines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Artificial Heart Lung Machines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Artificial Heart Lung Machines.
Chapter 14 and 15, to describe Artificial Heart Lung Machines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Artificial Heart Lung Machines Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Single Roller Pump HLM
1.3.3 Double Roller Pump HLM
1.4 Market Analysis by Surgical Type
1.4.1 Overview: Global Artificial Heart Lung Machines Consumption Value by Surgical Type: 2021 Versus 2025 Versus 2032
1.4.2 Open Surgery
1.4.3 Minimally Invasive
1.4.4 Emergency Surgery
1.5 Market Analysis by End Users
1.5.1 Overview: Global Artificial Heart Lung Machines Consumption Value by End Users: 2021 Versus 2025 Versus 2032
1.5.2 General Hospitals
1.5.3 Surgical Centers
1.5.4 Other
1.6 Market Analysis by Application
1.6.1 Overview: Global Artificial Heart Lung Machines Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Cardiac Surgery
1.6.3 Lung Transplant Operation
1.6.4 Acute Respiratory Failure Treatment
1.6.5 Others
1.7 Global Artificial Heart Lung Machines Market Size & Forecast
1.7.1 Global Artificial Heart Lung Machines Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Artificial Heart Lung Machines Sales Quantity (2021-2032)
1.7.3 Global Artificial Heart Lung Machines Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 LivaNova (Sorin)
2.1.1 LivaNova (Sorin) Details
2.1.2 LivaNova (Sorin) Major Business
2.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Product and Services
2.1.4 LivaNova (Sorin) Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 LivaNova (Sorin) Recent Developments/Updates
2.2 Getinge (Maquet)
2.2.1 Getinge (Maquet) Details
2.2.2 Getinge (Maquet) Major Business
2.2.3 Getinge (Maquet) Artificial Heart Lung Machines Product and Services
2.2.4 Getinge (Maquet) Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Getinge (Maquet) Recent Developments/Updates
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Artificial Heart Lung Machines Product and Services
2.3.4 Medtronic Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Medtronic Recent Developments/Updates
2.4 Terumo CV Group
2.4.1 Terumo CV Group Details
2.4.2 Terumo CV Group Major Business
2.4.3 Terumo CV Group Artificial Heart Lung Machines Product and Services
2.4.4 Terumo CV Group Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Terumo CV Group Recent Developments/Updates
2.5 Braile Biomedica
2.5.1 Braile Biomedica Details
2.5.2 Braile Biomedica Major Business
2.5.3 Braile Biomedica Artificial Heart Lung Machines Product and Services
2.5.4 Braile Biomedica Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Braile Biomedica Recent Developments/Updates
2.6 Shenzhen Hannuo
2.6.1 Shenzhen Hannuo Details
2.6.2 Shenzhen Hannuo Major Business
2.6.3 Shenzhen Hannuo Artificial Heart Lung Machines Product and Services
2.6.4 Shenzhen Hannuo Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Shenzhen Hannuo Recent Developments/Updates
2.7 Fresenius
2.7.1 Fresenius Details
2.7.2 Fresenius Major Business
2.7.3 Fresenius Artificial Heart Lung Machines Product and Services
2.7.4 Fresenius Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Fresenius Recent Developments/Updates
2.8 Changzheng Medical
2.8.1 Changzheng Medical Details
2.8.2 Changzheng Medical Major Business
2.8.3 Changzheng Medical Artificial Heart Lung Machines Product and Services
2.8.4 Changzheng Medical Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Changzheng Medical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ARTIFICIAL HEART LUNG MACHINES BY MANUFACTURER
3.1 Global Artificial Heart Lung Machines Sales Quantity by Manufacturer (2021-2026)
3.2 Global Artificial Heart Lung Machines Revenue by Manufacturer (2021-2026)
3.3 Global Artificial Heart Lung Machines Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Artificial Heart Lung Machines by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Artificial Heart Lung Machines Manufacturer Market Share in 2025
3.4.3 Top 6 Artificial Heart Lung Machines Manufacturer Market Share in 2025
3.5 Artificial Heart Lung Machines Market: Overall Company Footprint Analysis
3.5.1 Artificial Heart Lung Machines Market: Region Footprint
3.5.2 Artificial Heart Lung Machines Market: Company Product Type Footprint
3.5.3 Artificial Heart Lung Machines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Artificial Heart Lung Machines Market Size by Region
4.1.1 Global Artificial Heart Lung Machines Sales Quantity by Region (2021-2032)
4.1.2 Global Artificial Heart Lung Machines Consumption Value by Region (2021-2032)
4.1.3 Global Artificial Heart Lung Machines Average Price by Region (2021-2032)
4.2 North America Artificial Heart Lung Machines Consumption Value (2021-2032)
4.3 Europe Artificial Heart Lung Machines Consumption Value (2021-2032)
4.4 Asia-Pacific Artificial Heart Lung Machines Consumption Value (2021-2032)
4.5 South America Artificial Heart Lung Machines Consumption Value (2021-2032)
4.6 Middle East & Africa Artificial Heart Lung Machines Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Artificial Heart Lung Machines Sales Quantity by Type (2021-2032)
5.2 Global Artificial Heart Lung Machines Consumption Value by Type (2021-2032)
5.3 Global Artificial Heart Lung Machines Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Artificial Heart Lung Machines Sales Quantity by Application (2021-2032)
6.2 Global Artificial Heart Lung Machines Consumption Value by Application (2021-2032)
6.3 Global Artificial Heart Lung Machines Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Artificial Heart Lung Machines Sales Quantity by Type (2021-2032)
7.2 North America Artificial Heart Lung Machines Sales Quantity by Application (2021-2032)
7.3 North America Artificial Heart Lung Machines Market Size by Country
7.3.1 North America Artificial Heart Lung Machines Sales Quantity by Country (2021-2032)
7.3.2 North America Artificial Heart Lung Machines Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Artificial Heart Lung Machines Sales Quantity by Type (2021-2032)
8.2 Europe Artificial Heart Lung Machines Sales Quantity by Application (2021-2032)
8.3 Europe Artificial Heart Lung Machines Market Size by Country
8.3.1 Europe Artificial Heart Lung Machines Sales Quantity by Country (2021-2032)
8.3.2 Europe Artificial Heart Lung Machines Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Artificial Heart Lung Machines Market Size by Region
9.3.1 Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Artificial Heart Lung Machines Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Artificial Heart Lung Machines Sales Quantity by Type (2021-2032)
10.2 South America Artificial Heart Lung Machines Sales Quantity by Application (2021-2032)
10.3 South America Artificial Heart Lung Machines Market Size by Country
10.3.1 South America Artificial Heart Lung Machines Sales Quantity by Country (2021-2032)
10.3.2 South America Artificial Heart Lung Machines Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Artificial Heart Lung Machines Market Size by Country
11.3.1 Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Artificial Heart Lung Machines Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Artificial Heart Lung Machines Market Drivers
12.2 Artificial Heart Lung Machines Market Restraints
12.3 Artificial Heart Lung Machines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Artificial Heart Lung Machines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Artificial Heart Lung Machines
13.3 Artificial Heart Lung Machines Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Artificial Heart Lung Machines Typical Distributors
14.3 Artificial Heart Lung Machines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Artificial Heart Lung Machines Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Single Roller Pump HLM
1.3.3 Double Roller Pump HLM
1.4 Market Analysis by Surgical Type
1.4.1 Overview: Global Artificial Heart Lung Machines Consumption Value by Surgical Type: 2021 Versus 2025 Versus 2032
1.4.2 Open Surgery
1.4.3 Minimally Invasive
1.4.4 Emergency Surgery
1.5 Market Analysis by End Users
1.5.1 Overview: Global Artificial Heart Lung Machines Consumption Value by End Users: 2021 Versus 2025 Versus 2032
1.5.2 General Hospitals
1.5.3 Surgical Centers
1.5.4 Other
1.6 Market Analysis by Application
1.6.1 Overview: Global Artificial Heart Lung Machines Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Cardiac Surgery
1.6.3 Lung Transplant Operation
1.6.4 Acute Respiratory Failure Treatment
1.6.5 Others
1.7 Global Artificial Heart Lung Machines Market Size & Forecast
1.7.1 Global Artificial Heart Lung Machines Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Artificial Heart Lung Machines Sales Quantity (2021-2032)
1.7.3 Global Artificial Heart Lung Machines Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 LivaNova (Sorin)
2.1.1 LivaNova (Sorin) Details
2.1.2 LivaNova (Sorin) Major Business
2.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Product and Services
2.1.4 LivaNova (Sorin) Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 LivaNova (Sorin) Recent Developments/Updates
2.2 Getinge (Maquet)
2.2.1 Getinge (Maquet) Details
2.2.2 Getinge (Maquet) Major Business
2.2.3 Getinge (Maquet) Artificial Heart Lung Machines Product and Services
2.2.4 Getinge (Maquet) Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Getinge (Maquet) Recent Developments/Updates
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Artificial Heart Lung Machines Product and Services
2.3.4 Medtronic Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Medtronic Recent Developments/Updates
2.4 Terumo CV Group
2.4.1 Terumo CV Group Details
2.4.2 Terumo CV Group Major Business
2.4.3 Terumo CV Group Artificial Heart Lung Machines Product and Services
2.4.4 Terumo CV Group Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Terumo CV Group Recent Developments/Updates
2.5 Braile Biomedica
2.5.1 Braile Biomedica Details
2.5.2 Braile Biomedica Major Business
2.5.3 Braile Biomedica Artificial Heart Lung Machines Product and Services
2.5.4 Braile Biomedica Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Braile Biomedica Recent Developments/Updates
2.6 Shenzhen Hannuo
2.6.1 Shenzhen Hannuo Details
2.6.2 Shenzhen Hannuo Major Business
2.6.3 Shenzhen Hannuo Artificial Heart Lung Machines Product and Services
2.6.4 Shenzhen Hannuo Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Shenzhen Hannuo Recent Developments/Updates
2.7 Fresenius
2.7.1 Fresenius Details
2.7.2 Fresenius Major Business
2.7.3 Fresenius Artificial Heart Lung Machines Product and Services
2.7.4 Fresenius Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Fresenius Recent Developments/Updates
2.8 Changzheng Medical
2.8.1 Changzheng Medical Details
2.8.2 Changzheng Medical Major Business
2.8.3 Changzheng Medical Artificial Heart Lung Machines Product and Services
2.8.4 Changzheng Medical Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Changzheng Medical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ARTIFICIAL HEART LUNG MACHINES BY MANUFACTURER
3.1 Global Artificial Heart Lung Machines Sales Quantity by Manufacturer (2021-2026)
3.2 Global Artificial Heart Lung Machines Revenue by Manufacturer (2021-2026)
3.3 Global Artificial Heart Lung Machines Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Artificial Heart Lung Machines by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Artificial Heart Lung Machines Manufacturer Market Share in 2025
3.4.3 Top 6 Artificial Heart Lung Machines Manufacturer Market Share in 2025
3.5 Artificial Heart Lung Machines Market: Overall Company Footprint Analysis
3.5.1 Artificial Heart Lung Machines Market: Region Footprint
3.5.2 Artificial Heart Lung Machines Market: Company Product Type Footprint
3.5.3 Artificial Heart Lung Machines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Artificial Heart Lung Machines Market Size by Region
4.1.1 Global Artificial Heart Lung Machines Sales Quantity by Region (2021-2032)
4.1.2 Global Artificial Heart Lung Machines Consumption Value by Region (2021-2032)
4.1.3 Global Artificial Heart Lung Machines Average Price by Region (2021-2032)
4.2 North America Artificial Heart Lung Machines Consumption Value (2021-2032)
4.3 Europe Artificial Heart Lung Machines Consumption Value (2021-2032)
4.4 Asia-Pacific Artificial Heart Lung Machines Consumption Value (2021-2032)
4.5 South America Artificial Heart Lung Machines Consumption Value (2021-2032)
4.6 Middle East & Africa Artificial Heart Lung Machines Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Artificial Heart Lung Machines Sales Quantity by Type (2021-2032)
5.2 Global Artificial Heart Lung Machines Consumption Value by Type (2021-2032)
5.3 Global Artificial Heart Lung Machines Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Artificial Heart Lung Machines Sales Quantity by Application (2021-2032)
6.2 Global Artificial Heart Lung Machines Consumption Value by Application (2021-2032)
6.3 Global Artificial Heart Lung Machines Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Artificial Heart Lung Machines Sales Quantity by Type (2021-2032)
7.2 North America Artificial Heart Lung Machines Sales Quantity by Application (2021-2032)
7.3 North America Artificial Heart Lung Machines Market Size by Country
7.3.1 North America Artificial Heart Lung Machines Sales Quantity by Country (2021-2032)
7.3.2 North America Artificial Heart Lung Machines Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Artificial Heart Lung Machines Sales Quantity by Type (2021-2032)
8.2 Europe Artificial Heart Lung Machines Sales Quantity by Application (2021-2032)
8.3 Europe Artificial Heart Lung Machines Market Size by Country
8.3.1 Europe Artificial Heart Lung Machines Sales Quantity by Country (2021-2032)
8.3.2 Europe Artificial Heart Lung Machines Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Artificial Heart Lung Machines Market Size by Region
9.3.1 Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Artificial Heart Lung Machines Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Artificial Heart Lung Machines Sales Quantity by Type (2021-2032)
10.2 South America Artificial Heart Lung Machines Sales Quantity by Application (2021-2032)
10.3 South America Artificial Heart Lung Machines Market Size by Country
10.3.1 South America Artificial Heart Lung Machines Sales Quantity by Country (2021-2032)
10.3.2 South America Artificial Heart Lung Machines Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Artificial Heart Lung Machines Market Size by Country
11.3.1 Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Artificial Heart Lung Machines Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Artificial Heart Lung Machines Market Drivers
12.2 Artificial Heart Lung Machines Market Restraints
12.3 Artificial Heart Lung Machines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Artificial Heart Lung Machines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Artificial Heart Lung Machines
13.3 Artificial Heart Lung Machines Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Artificial Heart Lung Machines Typical Distributors
14.3 Artificial Heart Lung Machines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Artificial Heart Lung Machines Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Artificial Heart Lung Machines Consumption Value by Surgical Type, (USD Million), 2021 & 2025 & 2032
Table 3. Global Artificial Heart Lung Machines Consumption Value by End Users, (USD Million), 2021 & 2025 & 2032
Table 4. Global Artificial Heart Lung Machines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. LivaNova (Sorin) Basic Information, Manufacturing Base and Competitors
Table 6. LivaNova (Sorin) Major Business
Table 7. LivaNova (Sorin) Artificial Heart Lung Machines Product and Services
Table 8. LivaNova (Sorin) Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. LivaNova (Sorin) Recent Developments/Updates
Table 10. Getinge (Maquet) Basic Information, Manufacturing Base and Competitors
Table 11. Getinge (Maquet) Major Business
Table 12. Getinge (Maquet) Artificial Heart Lung Machines Product and Services
Table 13. Getinge (Maquet) Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Getinge (Maquet) Recent Developments/Updates
Table 15. Medtronic Basic Information, Manufacturing Base and Competitors
Table 16. Medtronic Major Business
Table 17. Medtronic Artificial Heart Lung Machines Product and Services
Table 18. Medtronic Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Medtronic Recent Developments/Updates
Table 20. Terumo CV Group Basic Information, Manufacturing Base and Competitors
Table 21. Terumo CV Group Major Business
Table 22. Terumo CV Group Artificial Heart Lung Machines Product and Services
Table 23. Terumo CV Group Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Terumo CV Group Recent Developments/Updates
Table 25. Braile Biomedica Basic Information, Manufacturing Base and Competitors
Table 26. Braile Biomedica Major Business
Table 27. Braile Biomedica Artificial Heart Lung Machines Product and Services
Table 28. Braile Biomedica Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Braile Biomedica Recent Developments/Updates
Table 30. Shenzhen Hannuo Basic Information, Manufacturing Base and Competitors
Table 31. Shenzhen Hannuo Major Business
Table 32. Shenzhen Hannuo Artificial Heart Lung Machines Product and Services
Table 33. Shenzhen Hannuo Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Shenzhen Hannuo Recent Developments/Updates
Table 35. Fresenius Basic Information, Manufacturing Base and Competitors
Table 36. Fresenius Major Business
Table 37. Fresenius Artificial Heart Lung Machines Product and Services
Table 38. Fresenius Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Fresenius Recent Developments/Updates
Table 40. Changzheng Medical Basic Information, Manufacturing Base and Competitors
Table 41. Changzheng Medical Major Business
Table 42. Changzheng Medical Artificial Heart Lung Machines Product and Services
Table 43. Changzheng Medical Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Changzheng Medical Recent Developments/Updates
Table 45. Global Artificial Heart Lung Machines Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 46. Global Artificial Heart Lung Machines Revenue by Manufacturer (2021-2026) & (USD Million)
Table 47. Global Artificial Heart Lung Machines Average Price by Manufacturer (2021-2026) & (K US$/Unit)
Table 48. Market Position of Manufacturers in Artificial Heart Lung Machines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 49. Head Office and Artificial Heart Lung Machines Production Site of Key Manufacturer
Table 50. Artificial Heart Lung Machines Market: Company Product Type Footprint
Table 51. Artificial Heart Lung Machines Market: Company Product Application Footprint
Table 52. Artificial Heart Lung Machines New Market Entrants and Barriers to Market Entry
Table 53. Artificial Heart Lung Machines Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global Artificial Heart Lung Machines Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 55. Global Artificial Heart Lung Machines Sales Quantity by Region (2021-2026) & (Units)
Table 56. Global Artificial Heart Lung Machines Sales Quantity by Region (2027-2032) & (Units)
Table 57. Global Artificial Heart Lung Machines Consumption Value by Region (2021-2026) & (USD Million)
Table 58. Global Artificial Heart Lung Machines Consumption Value by Region (2027-2032) & (USD Million)
Table 59. Global Artificial Heart Lung Machines Average Price by Region (2021-2026) & (K US$/Unit)
Table 60. Global Artificial Heart Lung Machines Average Price by Region (2027-2032) & (K US$/Unit)
Table 61. Global Artificial Heart Lung Machines Sales Quantity by Type (2021-2026) & (Units)
Table 62. Global Artificial Heart Lung Machines Sales Quantity by Type (2027-2032) & (Units)
Table 63. Global Artificial Heart Lung Machines Consumption Value by Type (2021-2026) & (USD Million)
Table 64. Global Artificial Heart Lung Machines Consumption Value by Type (2027-2032) & (USD Million)
Table 65. Global Artificial Heart Lung Machines Average Price by Type (2021-2026) & (K US$/Unit)
Table 66. Global Artificial Heart Lung Machines Average Price by Type (2027-2032) & (K US$/Unit)
Table 67. Global Artificial Heart Lung Machines Sales Quantity by Application (2021-2026) & (Units)
Table 68. Global Artificial Heart Lung Machines Sales Quantity by Application (2027-2032) & (Units)
Table 69. Global Artificial Heart Lung Machines Consumption Value by Application (2021-2026) & (USD Million)
Table 70. Global Artificial Heart Lung Machines Consumption Value by Application (2027-2032) & (USD Million)
Table 71. Global Artificial Heart Lung Machines Average Price by Application (2021-2026) & (K US$/Unit)
Table 72. Global Artificial Heart Lung Machines Average Price by Application (2027-2032) & (K US$/Unit)
Table 73. North America Artificial Heart Lung Machines Sales Quantity by Type (2021-2026) & (Units)
Table 74. North America Artificial Heart Lung Machines Sales Quantity by Type (2027-2032) & (Units)
Table 75. North America Artificial Heart Lung Machines Sales Quantity by Application (2021-2026) & (Units)
Table 76. North America Artificial Heart Lung Machines Sales Quantity by Application (2027-2032) & (Units)
Table 77. North America Artificial Heart Lung Machines Sales Quantity by Country (2021-2026) & (Units)
Table 78. North America Artificial Heart Lung Machines Sales Quantity by Country (2027-2032) & (Units)
Table 79. North America Artificial Heart Lung Machines Consumption Value by Country (2021-2026) & (USD Million)
Table 80. North America Artificial Heart Lung Machines Consumption Value by Country (2027-2032) & (USD Million)
Table 81. Europe Artificial Heart Lung Machines Sales Quantity by Type (2021-2026) & (Units)
Table 82. Europe Artificial Heart Lung Machines Sales Quantity by Type (2027-2032) & (Units)
Table 83. Europe Artificial Heart Lung Machines Sales Quantity by Application (2021-2026) & (Units)
Table 84. Europe Artificial Heart Lung Machines Sales Quantity by Application (2027-2032) & (Units)
Table 85. Europe Artificial Heart Lung Machines Sales Quantity by Country (2021-2026) & (Units)
Table 86. Europe Artificial Heart Lung Machines Sales Quantity by Country (2027-2032) & (Units)
Table 87. Europe Artificial Heart Lung Machines Consumption Value by Country (2021-2026) & (USD Million)
Table 88. Europe Artificial Heart Lung Machines Consumption Value by Country (2027-2032) & (USD Million)
Table 89. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Type (2021-2026) & (Units)
Table 90. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Type (2027-2032) & (Units)
Table 91. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Application (2021-2026) & (Units)
Table 92. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Application (2027-2032) & (Units)
Table 93. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Region (2021-2026) & (Units)
Table 94. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Region (2027-2032) & (Units)
Table 95. Asia-Pacific Artificial Heart Lung Machines Consumption Value by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Artificial Heart Lung Machines Consumption Value by Region (2027-2032) & (USD Million)
Table 97. South America Artificial Heart Lung Machines Sales Quantity by Type (2021-2026) & (Units)
Table 98. South America Artificial Heart Lung Machines Sales Quantity by Type (2027-2032) & (Units)
Table 99. South America Artificial Heart Lung Machines Sales Quantity by Application (2021-2026) & (Units)
Table 100. South America Artificial Heart Lung Machines Sales Quantity by Application (2027-2032) & (Units)
Table 101. South America Artificial Heart Lung Machines Sales Quantity by Country (2021-2026) & (Units)
Table 102. South America Artificial Heart Lung Machines Sales Quantity by Country (2027-2032) & (Units)
Table 103. South America Artificial Heart Lung Machines Consumption Value by Country (2021-2026) & (USD Million)
Table 104. South America Artificial Heart Lung Machines Consumption Value by Country (2027-2032) & (USD Million)
Table 105. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Type (2021-2026) & (Units)
Table 106. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Type (2027-2032) & (Units)
Table 107. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Application (2021-2026) & (Units)
Table 108. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Application (2027-2032) & (Units)
Table 109. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Country (2021-2026) & (Units)
Table 110. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Country (2027-2032) & (Units)
Table 111. Middle East & Africa Artificial Heart Lung Machines Consumption Value by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Artificial Heart Lung Machines Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Artificial Heart Lung Machines Raw Material
Table 114. Key Manufacturers of Artificial Heart Lung Machines Raw Materials
Table 115. Artificial Heart Lung Machines Typical Distributors
Table 116. Artificial Heart Lung Machines Typical Customers
Table 1. Global Artificial Heart Lung Machines Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Artificial Heart Lung Machines Consumption Value by Surgical Type, (USD Million), 2021 & 2025 & 2032
Table 3. Global Artificial Heart Lung Machines Consumption Value by End Users, (USD Million), 2021 & 2025 & 2032
Table 4. Global Artificial Heart Lung Machines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. LivaNova (Sorin) Basic Information, Manufacturing Base and Competitors
Table 6. LivaNova (Sorin) Major Business
Table 7. LivaNova (Sorin) Artificial Heart Lung Machines Product and Services
Table 8. LivaNova (Sorin) Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. LivaNova (Sorin) Recent Developments/Updates
Table 10. Getinge (Maquet) Basic Information, Manufacturing Base and Competitors
Table 11. Getinge (Maquet) Major Business
Table 12. Getinge (Maquet) Artificial Heart Lung Machines Product and Services
Table 13. Getinge (Maquet) Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Getinge (Maquet) Recent Developments/Updates
Table 15. Medtronic Basic Information, Manufacturing Base and Competitors
Table 16. Medtronic Major Business
Table 17. Medtronic Artificial Heart Lung Machines Product and Services
Table 18. Medtronic Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Medtronic Recent Developments/Updates
Table 20. Terumo CV Group Basic Information, Manufacturing Base and Competitors
Table 21. Terumo CV Group Major Business
Table 22. Terumo CV Group Artificial Heart Lung Machines Product and Services
Table 23. Terumo CV Group Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Terumo CV Group Recent Developments/Updates
Table 25. Braile Biomedica Basic Information, Manufacturing Base and Competitors
Table 26. Braile Biomedica Major Business
Table 27. Braile Biomedica Artificial Heart Lung Machines Product and Services
Table 28. Braile Biomedica Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Braile Biomedica Recent Developments/Updates
Table 30. Shenzhen Hannuo Basic Information, Manufacturing Base and Competitors
Table 31. Shenzhen Hannuo Major Business
Table 32. Shenzhen Hannuo Artificial Heart Lung Machines Product and Services
Table 33. Shenzhen Hannuo Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Shenzhen Hannuo Recent Developments/Updates
Table 35. Fresenius Basic Information, Manufacturing Base and Competitors
Table 36. Fresenius Major Business
Table 37. Fresenius Artificial Heart Lung Machines Product and Services
Table 38. Fresenius Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Fresenius Recent Developments/Updates
Table 40. Changzheng Medical Basic Information, Manufacturing Base and Competitors
Table 41. Changzheng Medical Major Business
Table 42. Changzheng Medical Artificial Heart Lung Machines Product and Services
Table 43. Changzheng Medical Artificial Heart Lung Machines Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Changzheng Medical Recent Developments/Updates
Table 45. Global Artificial Heart Lung Machines Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 46. Global Artificial Heart Lung Machines Revenue by Manufacturer (2021-2026) & (USD Million)
Table 47. Global Artificial Heart Lung Machines Average Price by Manufacturer (2021-2026) & (K US$/Unit)
Table 48. Market Position of Manufacturers in Artificial Heart Lung Machines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 49. Head Office and Artificial Heart Lung Machines Production Site of Key Manufacturer
Table 50. Artificial Heart Lung Machines Market: Company Product Type Footprint
Table 51. Artificial Heart Lung Machines Market: Company Product Application Footprint
Table 52. Artificial Heart Lung Machines New Market Entrants and Barriers to Market Entry
Table 53. Artificial Heart Lung Machines Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global Artificial Heart Lung Machines Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 55. Global Artificial Heart Lung Machines Sales Quantity by Region (2021-2026) & (Units)
Table 56. Global Artificial Heart Lung Machines Sales Quantity by Region (2027-2032) & (Units)
Table 57. Global Artificial Heart Lung Machines Consumption Value by Region (2021-2026) & (USD Million)
Table 58. Global Artificial Heart Lung Machines Consumption Value by Region (2027-2032) & (USD Million)
Table 59. Global Artificial Heart Lung Machines Average Price by Region (2021-2026) & (K US$/Unit)
Table 60. Global Artificial Heart Lung Machines Average Price by Region (2027-2032) & (K US$/Unit)
Table 61. Global Artificial Heart Lung Machines Sales Quantity by Type (2021-2026) & (Units)
Table 62. Global Artificial Heart Lung Machines Sales Quantity by Type (2027-2032) & (Units)
Table 63. Global Artificial Heart Lung Machines Consumption Value by Type (2021-2026) & (USD Million)
Table 64. Global Artificial Heart Lung Machines Consumption Value by Type (2027-2032) & (USD Million)
Table 65. Global Artificial Heart Lung Machines Average Price by Type (2021-2026) & (K US$/Unit)
Table 66. Global Artificial Heart Lung Machines Average Price by Type (2027-2032) & (K US$/Unit)
Table 67. Global Artificial Heart Lung Machines Sales Quantity by Application (2021-2026) & (Units)
Table 68. Global Artificial Heart Lung Machines Sales Quantity by Application (2027-2032) & (Units)
Table 69. Global Artificial Heart Lung Machines Consumption Value by Application (2021-2026) & (USD Million)
Table 70. Global Artificial Heart Lung Machines Consumption Value by Application (2027-2032) & (USD Million)
Table 71. Global Artificial Heart Lung Machines Average Price by Application (2021-2026) & (K US$/Unit)
Table 72. Global Artificial Heart Lung Machines Average Price by Application (2027-2032) & (K US$/Unit)
Table 73. North America Artificial Heart Lung Machines Sales Quantity by Type (2021-2026) & (Units)
Table 74. North America Artificial Heart Lung Machines Sales Quantity by Type (2027-2032) & (Units)
Table 75. North America Artificial Heart Lung Machines Sales Quantity by Application (2021-2026) & (Units)
Table 76. North America Artificial Heart Lung Machines Sales Quantity by Application (2027-2032) & (Units)
Table 77. North America Artificial Heart Lung Machines Sales Quantity by Country (2021-2026) & (Units)
Table 78. North America Artificial Heart Lung Machines Sales Quantity by Country (2027-2032) & (Units)
Table 79. North America Artificial Heart Lung Machines Consumption Value by Country (2021-2026) & (USD Million)
Table 80. North America Artificial Heart Lung Machines Consumption Value by Country (2027-2032) & (USD Million)
Table 81. Europe Artificial Heart Lung Machines Sales Quantity by Type (2021-2026) & (Units)
Table 82. Europe Artificial Heart Lung Machines Sales Quantity by Type (2027-2032) & (Units)
Table 83. Europe Artificial Heart Lung Machines Sales Quantity by Application (2021-2026) & (Units)
Table 84. Europe Artificial Heart Lung Machines Sales Quantity by Application (2027-2032) & (Units)
Table 85. Europe Artificial Heart Lung Machines Sales Quantity by Country (2021-2026) & (Units)
Table 86. Europe Artificial Heart Lung Machines Sales Quantity by Country (2027-2032) & (Units)
Table 87. Europe Artificial Heart Lung Machines Consumption Value by Country (2021-2026) & (USD Million)
Table 88. Europe Artificial Heart Lung Machines Consumption Value by Country (2027-2032) & (USD Million)
Table 89. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Type (2021-2026) & (Units)
Table 90. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Type (2027-2032) & (Units)
Table 91. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Application (2021-2026) & (Units)
Table 92. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Application (2027-2032) & (Units)
Table 93. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Region (2021-2026) & (Units)
Table 94. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Region (2027-2032) & (Units)
Table 95. Asia-Pacific Artificial Heart Lung Machines Consumption Value by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Artificial Heart Lung Machines Consumption Value by Region (2027-2032) & (USD Million)
Table 97. South America Artificial Heart Lung Machines Sales Quantity by Type (2021-2026) & (Units)
Table 98. South America Artificial Heart Lung Machines Sales Quantity by Type (2027-2032) & (Units)
Table 99. South America Artificial Heart Lung Machines Sales Quantity by Application (2021-2026) & (Units)
Table 100. South America Artificial Heart Lung Machines Sales Quantity by Application (2027-2032) & (Units)
Table 101. South America Artificial Heart Lung Machines Sales Quantity by Country (2021-2026) & (Units)
Table 102. South America Artificial Heart Lung Machines Sales Quantity by Country (2027-2032) & (Units)
Table 103. South America Artificial Heart Lung Machines Consumption Value by Country (2021-2026) & (USD Million)
Table 104. South America Artificial Heart Lung Machines Consumption Value by Country (2027-2032) & (USD Million)
Table 105. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Type (2021-2026) & (Units)
Table 106. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Type (2027-2032) & (Units)
Table 107. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Application (2021-2026) & (Units)
Table 108. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Application (2027-2032) & (Units)
Table 109. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Country (2021-2026) & (Units)
Table 110. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Country (2027-2032) & (Units)
Table 111. Middle East & Africa Artificial Heart Lung Machines Consumption Value by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Artificial Heart Lung Machines Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Artificial Heart Lung Machines Raw Material
Table 114. Key Manufacturers of Artificial Heart Lung Machines Raw Materials
Table 115. Artificial Heart Lung Machines Typical Distributors
Table 116. Artificial Heart Lung Machines Typical Customers
LIST OF FIGURES
Figure 1. Artificial Heart Lung Machines Picture
Figure 2. Global Artificial Heart Lung Machines Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Artificial Heart Lung Machines Revenue Market Share by Type in 2025
Figure 4. Single Roller Pump HLM Examples
Figure 5. Double Roller Pump HLM Examples
Figure 6. Global Artificial Heart Lung Machines Revenue by Surgical Type, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Artificial Heart Lung Machines Revenue Market Share by Surgical Type in 2025
Figure 8. Open Surgery Examples
Figure 9. Minimally Invasive Examples
Figure 10. Emergency Surgery Examples
Figure 11. Global Artificial Heart Lung Machines Revenue by End Users, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Artificial Heart Lung Machines Revenue Market Share by End Users in 2025
Figure 13. General Hospitals Examples
Figure 14. Surgical Centers Examples
Figure 15. Other Examples
Figure 16. Global Artificial Heart Lung Machines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Artificial Heart Lung Machines Revenue Market Share by Application in 2025
Figure 18. Cardiac Surgery Examples
Figure 19. Lung Transplant Operation Examples
Figure 20. Acute Respiratory Failure Treatment Examples
Figure 21. Others Examples
Figure 22. Global Artificial Heart Lung Machines Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Artificial Heart Lung Machines Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Artificial Heart Lung Machines Sales Quantity (2021-2032) & (Units)
Figure 25. Global Artificial Heart Lung Machines Price (2021-2032) & (K US$/Unit)
Figure 26. Global Artificial Heart Lung Machines Sales Quantity Market Share by Manufacturer in 2025
Figure 27. Global Artificial Heart Lung Machines Revenue Market Share by Manufacturer in 2025
Figure 28. Producer Shipments of Artificial Heart Lung Machines by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 29. Top 3 Artificial Heart Lung Machines Manufacturer (Revenue) Market Share in 2025
Figure 30. Top 6 Artificial Heart Lung Machines Manufacturer (Revenue) Market Share in 2025
Figure 31. Global Artificial Heart Lung Machines Sales Quantity Market Share by Region (2021-2032)
Figure 32. Global Artificial Heart Lung Machines Consumption Value Market Share by Region (2021-2032)
Figure 33. North America Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 36. South America Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 38. Global Artificial Heart Lung Machines Sales Quantity Market Share by Type (2021-2032)
Figure 39. Global Artificial Heart Lung Machines Consumption Value Market Share by Type (2021-2032)
Figure 40. Global Artificial Heart Lung Machines Average Price by Type (2021-2032) & (K US$/Unit)
Figure 41. Global Artificial Heart Lung Machines Sales Quantity Market Share by Application (2021-2032)
Figure 42. Global Artificial Heart Lung Machines Revenue Market Share by Application (2021-2032)
Figure 43. Global Artificial Heart Lung Machines Average Price by Application (2021-2032) & (K US$/Unit)
Figure 44. North America Artificial Heart Lung Machines Sales Quantity Market Share by Type (2021-2032)
Figure 45. North America Artificial Heart Lung Machines Sales Quantity Market Share by Application (2021-2032)
Figure 46. North America Artificial Heart Lung Machines Sales Quantity Market Share by Country (2021-2032)
Figure 47. North America Artificial Heart Lung Machines Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Artificial Heart Lung Machines Sales Quantity Market Share by Type (2021-2032)
Figure 52. Europe Artificial Heart Lung Machines Sales Quantity Market Share by Application (2021-2032)
Figure 53. Europe Artificial Heart Lung Machines Sales Quantity Market Share by Country (2021-2032)
Figure 54. Europe Artificial Heart Lung Machines Consumption Value Market Share by Country (2021-2032)
Figure 55. Germany Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 56. France Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 57. United Kingdom Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 58. Russia Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 59. Italy Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 60. Asia-Pacific Artificial Heart Lung Machines Sales Quantity Market Share by Type (2021-2032)
Figure 61. Asia-Pacific Artificial Heart Lung Machines Sales Quantity Market Share by Application (2021-2032)
Figure 62. Asia-Pacific Artificial Heart Lung Machines Sales Quantity Market Share by Region (2021-2032)
Figure 63. Asia-Pacific Artificial Heart Lung Machines Consumption Value Market Share by Region (2021-2032)
Figure 64. China Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 65. Japan Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 66. South Korea Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 67. India Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 68. Southeast Asia Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 69. Australia Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 70. South America Artificial Heart Lung Machines Sales Quantity Market Share by Type (2021-2032)
Figure 71. South America Artificial Heart Lung Machines Sales Quantity Market Share by Application (2021-2032)
Figure 72. South America Artificial Heart Lung Machines Sales Quantity Market Share by Country (2021-2032)
Figure 73. South America Artificial Heart Lung Machines Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa Artificial Heart Lung Machines Sales Quantity Market Share by Type (2021-2032)
Figure 77. Middle East & Africa Artificial Heart Lung Machines Sales Quantity Market Share by Application (2021-2032)
Figure 78. Middle East & Africa Artificial Heart Lung Machines Sales Quantity Market Share by Country (2021-2032)
Figure 79. Middle East & Africa Artificial Heart Lung Machines Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 81. Egypt Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 82. Saudi Arabia Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 83. South Africa Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 84. Artificial Heart Lung Machines Market Drivers
Figure 85. Artificial Heart Lung Machines Market Restraints
Figure 86. Artificial Heart Lung Machines Market Trends
Figure 87. Porters Five Forces Analysis
Figure 88. Manufacturing Cost Structure Analysis of Artificial Heart Lung Machines in 2025
Figure 89. Manufacturing Process Analysis of Artificial Heart Lung Machines
Figure 90. Artificial Heart Lung Machines Industrial Chain
Figure 91. Sales Channel: Direct to End-User vs Distributors
Figure 92. Direct Channel Pros & Cons
Figure 93. Indirect Channel Pros & Cons
Figure 94. Methodology
Figure 95. Research Process and Data Source
Figure 1. Artificial Heart Lung Machines Picture
Figure 2. Global Artificial Heart Lung Machines Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Artificial Heart Lung Machines Revenue Market Share by Type in 2025
Figure 4. Single Roller Pump HLM Examples
Figure 5. Double Roller Pump HLM Examples
Figure 6. Global Artificial Heart Lung Machines Revenue by Surgical Type, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Artificial Heart Lung Machines Revenue Market Share by Surgical Type in 2025
Figure 8. Open Surgery Examples
Figure 9. Minimally Invasive Examples
Figure 10. Emergency Surgery Examples
Figure 11. Global Artificial Heart Lung Machines Revenue by End Users, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Artificial Heart Lung Machines Revenue Market Share by End Users in 2025
Figure 13. General Hospitals Examples
Figure 14. Surgical Centers Examples
Figure 15. Other Examples
Figure 16. Global Artificial Heart Lung Machines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Artificial Heart Lung Machines Revenue Market Share by Application in 2025
Figure 18. Cardiac Surgery Examples
Figure 19. Lung Transplant Operation Examples
Figure 20. Acute Respiratory Failure Treatment Examples
Figure 21. Others Examples
Figure 22. Global Artificial Heart Lung Machines Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Artificial Heart Lung Machines Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Artificial Heart Lung Machines Sales Quantity (2021-2032) & (Units)
Figure 25. Global Artificial Heart Lung Machines Price (2021-2032) & (K US$/Unit)
Figure 26. Global Artificial Heart Lung Machines Sales Quantity Market Share by Manufacturer in 2025
Figure 27. Global Artificial Heart Lung Machines Revenue Market Share by Manufacturer in 2025
Figure 28. Producer Shipments of Artificial Heart Lung Machines by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 29. Top 3 Artificial Heart Lung Machines Manufacturer (Revenue) Market Share in 2025
Figure 30. Top 6 Artificial Heart Lung Machines Manufacturer (Revenue) Market Share in 2025
Figure 31. Global Artificial Heart Lung Machines Sales Quantity Market Share by Region (2021-2032)
Figure 32. Global Artificial Heart Lung Machines Consumption Value Market Share by Region (2021-2032)
Figure 33. North America Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 36. South America Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 38. Global Artificial Heart Lung Machines Sales Quantity Market Share by Type (2021-2032)
Figure 39. Global Artificial Heart Lung Machines Consumption Value Market Share by Type (2021-2032)
Figure 40. Global Artificial Heart Lung Machines Average Price by Type (2021-2032) & (K US$/Unit)
Figure 41. Global Artificial Heart Lung Machines Sales Quantity Market Share by Application (2021-2032)
Figure 42. Global Artificial Heart Lung Machines Revenue Market Share by Application (2021-2032)
Figure 43. Global Artificial Heart Lung Machines Average Price by Application (2021-2032) & (K US$/Unit)
Figure 44. North America Artificial Heart Lung Machines Sales Quantity Market Share by Type (2021-2032)
Figure 45. North America Artificial Heart Lung Machines Sales Quantity Market Share by Application (2021-2032)
Figure 46. North America Artificial Heart Lung Machines Sales Quantity Market Share by Country (2021-2032)
Figure 47. North America Artificial Heart Lung Machines Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Artificial Heart Lung Machines Sales Quantity Market Share by Type (2021-2032)
Figure 52. Europe Artificial Heart Lung Machines Sales Quantity Market Share by Application (2021-2032)
Figure 53. Europe Artificial Heart Lung Machines Sales Quantity Market Share by Country (2021-2032)
Figure 54. Europe Artificial Heart Lung Machines Consumption Value Market Share by Country (2021-2032)
Figure 55. Germany Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 56. France Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 57. United Kingdom Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 58. Russia Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 59. Italy Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 60. Asia-Pacific Artificial Heart Lung Machines Sales Quantity Market Share by Type (2021-2032)
Figure 61. Asia-Pacific Artificial Heart Lung Machines Sales Quantity Market Share by Application (2021-2032)
Figure 62. Asia-Pacific Artificial Heart Lung Machines Sales Quantity Market Share by Region (2021-2032)
Figure 63. Asia-Pacific Artificial Heart Lung Machines Consumption Value Market Share by Region (2021-2032)
Figure 64. China Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 65. Japan Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 66. South Korea Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 67. India Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 68. Southeast Asia Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 69. Australia Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 70. South America Artificial Heart Lung Machines Sales Quantity Market Share by Type (2021-2032)
Figure 71. South America Artificial Heart Lung Machines Sales Quantity Market Share by Application (2021-2032)
Figure 72. South America Artificial Heart Lung Machines Sales Quantity Market Share by Country (2021-2032)
Figure 73. South America Artificial Heart Lung Machines Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa Artificial Heart Lung Machines Sales Quantity Market Share by Type (2021-2032)
Figure 77. Middle East & Africa Artificial Heart Lung Machines Sales Quantity Market Share by Application (2021-2032)
Figure 78. Middle East & Africa Artificial Heart Lung Machines Sales Quantity Market Share by Country (2021-2032)
Figure 79. Middle East & Africa Artificial Heart Lung Machines Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 81. Egypt Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 82. Saudi Arabia Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 83. South Africa Artificial Heart Lung Machines Consumption Value (2021-2032) & (USD Million)
Figure 84. Artificial Heart Lung Machines Market Drivers
Figure 85. Artificial Heart Lung Machines Market Restraints
Figure 86. Artificial Heart Lung Machines Market Trends
Figure 87. Porters Five Forces Analysis
Figure 88. Manufacturing Cost Structure Analysis of Artificial Heart Lung Machines in 2025
Figure 89. Manufacturing Process Analysis of Artificial Heart Lung Machines
Figure 90. Artificial Heart Lung Machines Industrial Chain
Figure 91. Sales Channel: Direct to End-User vs Distributors
Figure 92. Direct Channel Pros & Cons
Figure 93. Indirect Channel Pros & Cons
Figure 94. Methodology
Figure 95. Research Process and Data Source
